Profusa amends asset purchase agreement, eliminates management equity incentive
Profusa Inc. and Bio Insights LLC amended their April 2026 Asset Purchase Agreement for the PanOmics Platform by removing a provision requiring issuance of 12% equity to management for CEO/CFO retention. The modification suggests potential recalibration of deal economics or management compensation structure.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day